Pawar, Mercy
Busov, Boris
Chandrasekhar, Aaruran
Yao, Jingyu
Zacks, David N
Besirli, Cagri G
Article History
Received: 19 November 2016
Revised: 20 May 2017
Accepted: 25 May 2017
First Online: 14 July 2017
Competing interests
: Dr Besirli and Dr Zacks have intellectual property interests and are listed as inventors on a patent for the use of FAIM2 as a retinal neuroprotective treatment. The remaining authors declare no conflict of interest.